A Johns Hopkins University School of Nursing study concludes female victims of physical and/or sexual abuse have a significantly higher rate of common health problems, even after the abuse ends, compared to women who have never been abused.
A new drug blocks the impact of a cancer-causing gene mutation found in a common and lethal form of leukemia, say researchers at the Johns Hopkins Kimmel Cancer Center.
Researchers from the Johns Hopkins School of Medicine have learned that a protein that prevents the formation of cancerous tumors in animals also helps single-celled amoeba determine direction, particularly when moving toward a chemical attractant, an ability of many cell types in more complex creatures.
The Johns Hopkins researchers who first identified myostatin as a key restrictor of muscle growth in animals now report that excessive amounts of the protein in mice cause rapid and dramatic loss of both muscle and fat, without affecting appetite.
A bacterium responsible for the vast majority of stomach cancers, a leading cause of cancer death worldwide, and ulcers may have met its match, scientists from Johns Hopkins and the French National Scientific Research Center report.
Johns Hopkins AIDS researcher and immunologist Robert F. Siliciano, M.D., Ph.D., has been named a Howard Hughes Medical Institute (HHMI) investigator. He is one of 12 physician- scientists recently selected by HHMI for their achievements in patient-oriented research.
The Johns Hopkins University School of Medicine will award doctor of medicine degrees to 114 women and men from 25 states and six foreign countries at the commencement exercises May 23, 2002. The class is the 107th to graduate since the school opened in 1893. Johns Hopkins is among the most selective medical schools in the nation, with 4,654 applicants for 120 places for the freshman class this fall.
An implantable pump that delivers pain medication in a slow-release fashion directly into the spinal fluid could greatly improve the pain relief, overall quality of life and survival for cancer patients living in pain, according to an international study completed at Johns Hopkins, the Medical College of Virginia and 25 other medical centers.
A preliminary study has found no advantage to adding chemotherapy to radiation after surgery for treating advanced head and neck cancer patients. The findings of the research, to be presented at the American Society of Clinical Oncology meeting May 18, appear to set aside earlier data suggesting that a combination of chemotherapy and radiation would improve the odds of staying cancer-free after surgery.
A Johns Hopkins Children's Center scientist reports success in animal studies in preventing a cascade of brain pathology that appears to both cause and signal the final and fatal stages of acute and chronic liver disease in children and adults.
Scientists at the Johns Hopkins Kimmel Cancer Center have discovered that an enzyme found in a tumor cell's energy center has a special relationship with a gene that controls cancer cell growth and death. Their findings may offer a road map to anti-cancer therapies designed to manipulate the genetic pathway that switches the enzyme on and off.
Scientists from The Center for Hearing and Balance at Johns Hopkins have discovered how tiny cells in the inner ear change sound into an electrical signal the brain can understand.
By filtering kidney patients' blood of antibodies that normally would reject a donor kidney, transplant surgeons at Johns Hopkins have been 93 percent successful in transplanting the organs between any two people regardless of blood type or prior exposure to their tissue type.
Johns Hopkins scientists have found that simply increasing manganese in cells can halt HIV's unusual ability to process its genetic information backwards, providing a new way to target the process's key driver, an enzyme called reverse transcriptase.
Humans may be able to develop immunity to hepatitis C virus, according to a study by Hopkins researchers, findings that add to a growing body of evidence that immunity to the virus can be acquired. The findings are important because no vaccines exist for preventing hepatitis C in humans although preliminary vaccine research in primates appears promising.
Despite promising evidence that a gene closely linked to schizophrenia would be found on human chromosome number 1, an international team of scientists who scoured the chromosome in more than 1,900 patients concludes it isn't there.
Young men who quickly react to stress with anger are at three times the normal risk of developing premature heart disease, according to a Johns Hopkins study of more than 1,000 physicians.
The Johns Hopkins Hospital is one of eight worldwide sites chosen to conduct a Phase 3 clinical trial on the treatment of uterine fibroids using magnetic resonance imaging (MRI)-guided high intensity focused ultrasound.
Author William Styron and pediatric neurosurgeon Benjamin Carson, M.D., will be featured speakers at the annual symposium sponsored by the Johns Hopkins Affective Disorders Clinic and DRADA, the Depression and Related Affective Disorders Association. Noted Hopkins psychiatrist, writer and MacArthur Prize winner Kay Redfield Jamison will also speak.
Hopkins cancer researchers have identified a new genetic culprit-with dietary links-in the initiation of prostate cancer.
Heart attack patients may be better off with balloon angioplasty to open blocked blood vessels than with clot-busting drugs, even if their hospital lacks a cardiac surgery program, according to a Johns Hopkins-led study.
In experiments with fat cells, Johns Hopkins scientists have discovered direct evidence that a build-up of sugar on proteins triggers insulin resistance, a key feature of most cases of diabetes.
For what is believed to be the first time, scientists have unraveled the complicated genetics of an inherited intestinal disease, opening the door to revealing complete genetic pictures of other complex diseases. The findings underscore non-coding genetic regions' importance in disease.
The best of the best. The cream of the crop. Cliches may accurately describe the winners of this year's 25th annual Young Investigators' Day awards at The Johns Hopkins University School of Medicine, but their work is anything but run of the mill.
A lot has happened since 1978. Kings have fallen, conventional wisdoms have been squashed, villains slain and heroes brought to light. And that's just in laboratory dishes. April 11 marks the twenty-fifth annual Young Investigators' Day at Johns Hopkins.
This information tip sheet highlights research news from the Kimmel Cancer Center at Johns Hopkins that are the subject of presentations at the annual meeting of the American Association of Cancer Research.
Glaucoma is the leading cause of blindness among U.S. Hispanics, while cataracts are the leading cause of visual impairment, according to results of a national study led by Johns Hopkins researchers.
The anti-inflammatory drug sulindac may not have the colon cancer prevention properties once hoped for, say Johns Hopkins Kimmel Cancer Center researchers. Results of a four-year study show that sulindac did not prevent precancerous growths, called polyps, in young patients with a hereditary form of colon cancer. The drug may still have benefit in reducing polyps in older patients.
For the tenth straight year, the National Institutes of Health annual summary of grants to medical schools ranks The Johns Hopkins University School of Medicine the top recipient of federal research dollars in the United States.
Two Johns Hopkins studies have strongly affirmed the value of treadmill exercise tests in diagnosing heart disease in middle-aged women and men before symptoms occur.
A team of Hopkins scientists has greatly advanced the science of penile erection, showing for the first time the mechanism for continued production of nitric oxide that maintains an erection over time.
A diet rich in soy appears to decrease inflammation-induced pain in rats, according to a study by Johns Hopkins researchers.
The Phoebe R. Berman Bioethics Institute at The Johns Hopkins University has received a three-year, $9.9M grant from the Pew Charitable Trusts to establish the Genetics and Public Policy Center in Washington, D.C. The center's first initiative will focus on ethical and public policy issues related to genetics and human reproduction.
Researchers at Johns Hopkins and 54 eye-care centers across North America have found two competing methods of correcting a mild form of children's amblyopia -- pejoratively called "lazy eye"-- are equally effective in correcting the vision disorder.
After almost 10 years of research with cells and animals to learn what makes a certain enzyme act as a "bad guy" in the progressive and fatal disease amyotrophic lateral sclerosis (ALS), Johns Hopkins scientists report that a leading candidate -- copper -- is off the hook.
The recent decision by U.S. Attorney General John Ashcroft to challenge the legality of Oregon's physician-assisted suicide law has re-ignited debate over this thorny issue. In response to the fallout after Ashcroft's decision, the Phoebe R. Berman Bioethics Institute at Johns Hopkins will sponsor a two-part debate about whether the Oregon law should be allowed to stand, as part of the Harvey M. Meyerhoff Lectures on Ethics and the End of Life.
Instead of years of allergy shots that may only marginally reduce their symptoms, "hayfever" victims may soon be closer to getting substantially more effective control of their allergic problems with just six shots in six weeks.
Patients and physicians with questions about digestive diseases can turn to the newly launched Johns Hopkins Gastroenterology and Hepatology Resource Center, www.hopkins-gi.org, for answers.
Imagine dropping a bowl of spaghetti. That's what AVMs (arteriovenous malformations) look like in the brain -- dense clusters of twisting and turning blood vessels that look more like a wrestling match among a hundred small snakes than part of the circulatory system. Many patients don't know they have one. Some have crippling headaches. For the more unfortunate, the AVM ruptures, causing brain damage or death.
People with the rare bone disease oncogenic osteomalacia have the worst of both worlds. It may take years before their condition -- marked by tiny, noncancerous tumors that hide out and wreak havoc on the skeletal system -- is correctly diagnosed. Then more years can go by before physicians can precisely locate the tumors and remove them. Meanwhile, patients suffer debilitating bone pain, fractures and muscle weakness.
For mice genetically altered to get fat, knocking out a particular gene keeps them both leaner and healthier, Johns Hopkins School of Medicine scientists report.
Using genetically engineered mice, Johns Hopkins and other scientists have shown for the first time that a single kind of cell in the retina seems to detect light for the body's internal clock and for the pupil.
Expanding their studies of an experimental compound that causes dramatic weight loss and appetite suppression in mice, Johns Hopkins researchers now report that lean mice rapidly adjust to daily doses of the drug and get their appetites back, while their obese counterparts do not.
Hypoglycemia, or low blood sugar, may have a significant effect on activity patterns in a newborn's brain, say researchers at Johns Hopkins Children's Center and St. Christopher's Hospital for Children in Philadelphia.
Persistent mistrust of doctors and hospitals, and religious misconceptions may explain why more people, especially minorities, do not become blood and organ donors, Johns Hopkins researchers report.
In experiments with genetically engineered mice, Johns Hopkins researchers have found an "off-switch" for systemic inflammation, the body's overall response to injury and infection. The findings may have implications for treatment of inflammation-related diseases in humans, from autoimmune disorders to atherosclerosis, the researchers say.
Scientists at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins have developed a safe and reliable stool test that can detect the earliest, curable stages of colon cancer.
1) Johns Hopkins scientists find brain's nose plug; 2) Eat your veggies: indirect anti-oxidants provide long-term protection; 3) Tether for water channels found: may impact research on brain swelling.
A team of scientists led by drug maker Wyeth-Ayerst and Johns Hopkins have engineered and tested a new rat model of Lou Gehrig's disease they say is far easier to work with than earlier mouse models.
African Americans and Asians have a worse outcome than white Americans and Hispanics after liver transplantation, both in terms of graft rejection and survival.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right